In case you missed it, the Biotech sector has been making some pretty exciting moves this week. Of course, if you’re the kind of trader who sits back and waits for these things to happen you’re probably not capitalizing nearly as much as you could.
The NASDAQ Biotechnology IDX ($IBB) is currently reaching new highs after steadily increasing for the last year. Celegene ($CELG), who just acquired Receptos ($RCPT) is also seeing major activity to the upside.
Watch this short video below to see how the predictive technology in VantagePoint Software could have gotten you ahead of these major trends and put more profits back in your pocket.